Regulators face tough flu-jab choices

摘要

Imminent decisions on a strategy for H1N1 pandemic flu vaccination in the United States could leave other countries short of vital doses if it elects not to follow World Health Organization (WHO) advice on vaccine formulation.rnThe United States is the biggest buyer among a group of rich countries whose combined orders for vaccine against the H1N1 2009 virus could potentially tie up most of the worlds pandemic vaccine production capacity for 6 months or longer, so depriving other countries of vaccine.